(Q54195669)

26 May 2018

title

Urinary kallikrein and salt sensitivity in essential hypertensive males. (English)

1 reference

26 May 2018

author name string

Ferri C

1

1 reference

26 May 2018

Bellini C

2

1 reference

26 May 2018

Carlomagno A

3

1 reference

26 May 2018

Perrone A

4

1 reference

26 May 2018

Santucci A

5

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 September 1994

1 reference

26 May 2018

published in

Kidney International

1 reference

26 May 2018

volume

46

1 reference

26 May 2018

issue

3

1 reference

26 May 2018

page(s)

780-788

1 reference

26 May 2018

https://scigraph.springernature.com/pub.10.1038/ki.1994.333

exact match

0 references

cites work

An overview of randomized trials of sodium reduction and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

A Comprehensive Review of the Salt and Blood Pressure Relationship

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Association of haptoglobin with sodium sensitivity and resistance of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Membrane sodium transport and salt sensitivity of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Urinary kallikrein excretion and blood pressure response to angiotensin converting enzyme inhibitors and calcium antagonists in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

A gene for high urinary kallikrein may protect against hypertension in Utah kindreds

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Natriuretic hormones in young hypertensives and in young normotensives with or without a family history of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Methods for the Determination of Glandular Kallikrein by Means of a Chromogenic Tripeptide Substrate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Are non-modulating patients with essential hypertension a distinct subgroup? Implications for therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Salt sensitivity and resistance of blood pressure. Age and race as factors in physiological responses

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Racial and ethnic modifiers of the salt-blood pressure response

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Genetic traits related to hypertension and electrolyte metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Interactions among calcium, sodium, and alcohol intake as determinants of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Salt sensitivity. Definition, conception, methodology, and long-term issues

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Relationship of Sodium Balance to Arterial Pressure in Black Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Sodium intake, body sodium, and sodium excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Methodology of sodium sensitivity assessment. The example of age and sex.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Clinical interaction of salt and weight change on blood pressure level

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Role of salt in the control of blood pressure in obesity and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Corcoran lecture: the case for or against salt in hypertension. Arthur Curtis Corcoran, MD (1909-1965). Tribute and prelude to Corcoran Lecture of 1988.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Non-modulation as an intermediate phenotype in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Non-modulating hypertension. A subset of sodium-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Atrial natriuretic peptide in non-modulating essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Effects of high-sodium and low-sodium intake on circulating atrial natriuretic peptides in salt-sensitive patients with systemic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

The influence of salt sensitivity on the blood pressure response to exogenous kallikrein in essential hypertensive patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.333

7 January 2021

Identifiers

DOI

10.1038/KI.1994.333

1 reference

26 May 2018

PubMed ID

7996800

1 reference

26 May 2018